Key Record Dates
ClinicalTrials.gov Identifier: | NCT04381052 |
---|---|
Brief Title: | Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
First Submitted : | May 6, 2020 |
First Submitted that Met QC Criteria : | May 7, 2020 |
First Posted : | May 8, 2020 |
Last Update Submitted that Met QC Criteria : | May 7, 2020 |
Last Update Posted : | May 8, 2020 |